Efavirenz as a potential drug for the treatment of triple-negative breast cancers

被引:0
|
作者
P.-T. Chiou
S. Ohms
P. G. Board
J. E. Dahlstrom
D. Rangasamy
M. G. Casarotto
机构
[1] The Australian National University,ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research
[2] The Australian National University,The John Curtin School of Medical Research
[3] The Australian National University,Anatomical Pathology, ACT Pathology, Canberra Hospital and ANU Medical School, ANU College of Health and Medicine
来源
关键词
Triple-negative breast cancer; Efavirenz; LINE-1; Retrotransposon; Fatty acid metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:353 / 363
页数:10
相关论文
共 50 条
  • [1] Efavirenz as a potential drug for the treatment of triple-negative breast cancers
    Chiou, P-T
    Ohms, S.
    Board, P. G.
    Dahlstrom, J. E.
    Rangasamy, D.
    Casarotto, M. G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (02): : 353 - 363
  • [2] Triple-negative breast cancers
    Narod, Steven A.
    Dent, Rebecca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (10) : 1041 - 1043
  • [3] Novel treatment options for triple-negative breast cancers
    Hastak, Kedar
    Alli, Elizabeth
    Ford, James M.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3573S - 3573S
  • [4] NF-B Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers
    Poma, Paola
    Labbozzetta, Manuela
    D'Alessandro, Natale
    Notarbartolo, Monica
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2017, 21 (04) : 225 - 231
  • [5] The Omics of Triple-Negative Breast Cancers
    Xu, Hong
    Eirew, Peter
    Mullaly, Sarah C.
    Aparicio, Samuel
    CLINICAL CHEMISTRY, 2014, 60 (01) : 122 - 133
  • [6] Triple-negative breast cancers: an updated review on treatment options
    Reddy, K. B.
    CURRENT ONCOLOGY, 2011, 18 (04) : E173 - E179
  • [7] Subclassifying triple-negative breast cancers and its potential clinical utility
    Jing Lian
    Hai-xia Ma
    En-Wei Xu
    Peng Bu
    Ke-Ming Yun
    Yan-Feng Xi
    Virchows Archiv, 2022, 481 : 13 - 21
  • [8] Subclassifying triple-negative breast cancers and its potential clinical utility
    Lian, Jing
    Ma, Hai-Xia
    Xu, En-Wei
    Bu, Peng
    Yun, Ke-Ming
    Xi, Yan-Feng
    VIRCHOWS ARCHIV, 2022, 481 (01) : 13 - 21
  • [9] Molecular Stratification of Triple-Negative Breast Cancers
    Perou, Charles M.
    ONCOLOGIST, 2010, 15 : 39 - 48
  • [10] Clinicopathological characteristics of triple-negative breast cancers
    Yuka Sasaki
    Hitoshi Tsuda
    Breast Cancer, 2009, 16 : 254 - 259